Skip to main content
[Preprint]. 2023 Apr 13:2023.04.12.536558. [Version 1] doi: 10.1101/2023.04.12.536558

Figure 6. Increased renal glucose production promotes RCC tumor progression.

Figure 6.

(A) Representative images of kidney stained with hematoxylin & eosin from Renca tumor-bearing mice treated with propranolol. (B) Treatment with the Adrb antagonist propranolol slows Renca tumor progression in mice (n=8 controls and 7 propranolol-treated mice). *P<0.05. (C) RCC patients who have ever been prescribed propranolol have improved survival as compared to RCC patients who have never taken propranolol. The 95% confidence interval is shown.